B. Fischer
Schizophrenia bulletin · 2010–2016
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Who trusts B. Fischer overall
Papers from B. Fischer's perspective
Ordered by how strongly the researchers B. Fischer trusts endorse each paper. Same corpus, a different order for every researcher.
- The positive and negative syndrome scale (PANSS) for schizophrenia.
- Second-Generation (Atypical) Antipsychotics and Metabolic Effects (CNS Drugs)
- Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. (New England Journal of Medicine)
- Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. (American Journal of Psychiatry)
- Dementia praecox and paraphrenia
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. (The Lancet)
- Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). (Archives of General Psychiatry)
- Mortality and causes of death in schizophrenia in Stockholm county, Sweden. (Schizophrenia Research)
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. (The Lancet)
- Anticipatory and consummatory components of the experience of pleasure: A scale development study
Their papers
- Lessons Learned. (2016) — 944 citations
- The brief negative symptom scale: psychometric properties. (2011) — 855 citations
- The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. (2010) — 833 citations